KYMERA THERAPEUTICS I
43.37
08-十月-24 11:25:08
15 分钟延时
股票
+1.16
+2.75%
今日范围
42.41 - 43.62
ISIN
N/A
来源
NASDAQ
-
Kymera Therapeutics to Participate in Upcoming September Investor Conferences
28 8月 2023 06:00:00 条件 Nasdaq GlobeNewswire
-
Kymera Therapeutics Announces Second Quarter 2023 Financial Results and Provides a Business Update
03 8月 2023 06:00:01 条件 Nasdaq GlobeNewswire
-
Kymera Therapeutics to Report Second Quarter 2023 Financial Results on August 3
27 7月 2023 06:00:01 条件 Nasdaq GlobeNewswire
-
22 6月 2023 07:30:00 条件 Nasdaq GlobeNewswire
-
09 6月 2023 17:00:00 条件 Nasdaq GlobeNewswire
-
Kymera Therapeutics to Participate in Upcoming June Investor Conference
01 6月 2023 06:00:00 条件 Nasdaq GlobeNewswire
-
Kymera Appoints Jeremy Chadwick, Ph.D., as Chief Operating Officer
22 5月 2023 06:00:00 条件 Nasdaq GlobeNewswire
-
Kymera Therapeutics Doses First Patient in Phase 1 Oncology Trial of MDM2 Degrader KT-253
19 5月 2023 06:00:00 条件 Nasdaq GlobeNewswire
-
18 5月 2023 06:00:01 条件 Nasdaq GlobeNewswire
-
Kymera Therapeutics Announces First Quarter 2023 Financial Results and Provides a Business Update
04 5月 2023 06:00:01 条件 Nasdaq GlobeNewswire
-
Kymera Therapeutics to Report First Quarter 2023 Financial Results on May 4
11 4月 2023 06:00:00 条件 Nasdaq GlobeNewswire
-
Kymera Therapeutics to Participate in Upcoming March Investor Conferences
01 3月 2023 06:00:02 条件 Nasdaq GlobeNewswire
-
23 2月 2023 06:00:01 条件 Nasdaq GlobeNewswire
-
Kymera Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on February 23
01 2月 2023 06:00:00 条件 Nasdaq GlobeNewswire
-
10 1月 2023 06:00:00 条件 Nasdaq GlobeNewswire
-
Kymera Appoints Ellen Chiniara, J.D., as Chief Legal Officer and Corporate Secretary
04 1月 2023 06:00:02 条件 Nasdaq GlobeNewswire
-
03 1月 2023 06:00:00 条件 Nasdaq GlobeNewswire